Li Haiyang, Li Pingdong, Li Feng, Wang Tao
Department of Otolaryngology, Beijing Daxing District People's Hospital, Beijing 102600, P.R. China.
Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, P.R. China.
Oncol Lett. 2024 Dec 13;29(2):100. doi: 10.3892/ol.2024.14846. eCollection 2025 Feb.
The aim of the present study was to employ CELLSEARCH technology for the detection of circulating tumor cells (CTCs) in the peripheral blood of head and neck cancer (HNC) patients, and to assess the association between CTC count and patient prognosis. In this retrospective study, a cohort of 56 patients diagnosed with HNC and receiving treatment at the Department of Otolaryngology, Head and Neck Surgery (Beijing Tongren Hospital) between December 2013 and June 2018 were selected. Utilizing CELLSEARCH technology, the presence of CTCs were detected in samples of peripheral blood from patients with head and neck cancer (HNC) patients, and CTC counts were documented. CTC positivity was defined as CTCs ≥1/7.5 ml of peripheral blood. Comprehensive data encompassing general demographic profiles, pathological classifications, tumor node metastasis (TNM) staging, tumor histology and treatment modalities were gathered for each participant. The study employed the Kaplan-Meier method to scrutinize and compare survival rates between CTC-positive and CTC-negative cohorts, while both univariate and multivariate Cox regression analyses were conducted to discern the factors impacting the overall survival (OS) of individuals diagnosed with HNC. Out of the 56 patients examined, 14 individuals exhibited detectable levels of CTCs, resulting in a positivity rate of 25%. The analysis revealed a significant association between the levels of CTCs in patients with HNC and the utilization of non-surgical treatment (P<0.05), while no substantial associations were observed concerning sex, age, smoking habits, alcohol consumption, pathological classifications, TNM staging, tumor attributes and surgical interventions (all P>0.05). Survival analysis revealed a reduction in the OS among patients with HNC harboring CTC positivity in contrast to their CTC-negative counterparts. The comprehensive multivariate Cox regression analysis underscored the independent prognostic impact of CTC presence (HR=1.274; 95% CI, 1.119-1.451; P<0.001) and the implementation of non-surgical treatment (HR=0.268; 95% CI, 0.119-0.607; P=0.002) on the prognosis of individuals grappling with HNC. In conclusion, the levels of CTCs were an independent factor affecting outcomes in patients with HNC, with CTC-positive patients showing significantly shorter survival compared with CTC-negative cases.
本研究的目的是采用CELLSEARCH技术检测头颈部癌(HNC)患者外周血中的循环肿瘤细胞(CTC),并评估CTC计数与患者预后之间的关联。在这项回顾性研究中,选取了2013年12月至2018年6月期间在北京同仁医院耳鼻咽喉头颈外科被诊断为HNC并接受治疗的56例患者。利用CELLSEARCH技术,检测头颈部癌(HNC)患者外周血样本中CTC的存在情况,并记录CTC计数。CTC阳性定义为每7.5毫升外周血中CTC≥1个。收集了每位参与者的综合数据,包括一般人口统计学资料、病理分类、肿瘤淋巴结转移(TNM)分期、肿瘤组织学和治疗方式。本研究采用Kaplan-Meier方法检查和比较CTC阳性组和CTC阴性组之间的生存率,同时进行单因素和多因素Cox回归分析,以确定影响HNC患者总生存期(OS)的因素。在检查的56例患者中,14例患者检测到可检测水平的CTC,阳性率为25%。分析显示,HNC患者的CTC水平与非手术治疗的使用之间存在显著关联(P<0.05),而在性别、年龄、吸烟习惯、饮酒、病理分类、TNM分期、肿瘤属性和手术干预方面未观察到显著关联(所有P>0.05)。生存分析显示HNC患者中CTC阳性者的OS低于CTC阴性者。综合多因素Cox回归分析强调了CTC存在(HR=1.274;95%CI,1.119-1.451;P<0.001)和非手术治疗的实施(HR=0.268;95%CI,0.119-0.607;P=0.002)对HNC患者预后的独立预后影响。总之,CTC水平是影响HNC患者预后的独立因素,CTC阳性患者的生存期明显短于CTC阴性患者。